4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0001575202-26-000011
Options or other derivatives
- Director acquired 83,123.16 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| GUJRATHI SHEILA Director | 2026-07-28 | Grant or award · Series A Preferred Stock | +70,811.88 | 70,811.88 | D | ||
| GUJRATHI SHEILA Director | 2026-07-28 | Grant or award · Series A Preferred Stock | +12,311.28 | 12,311.28 | I | ||
Loading xslF345X06/form4-07312026_010752.xml…